ID

16329

Beschreibung

Assessment of Endometrial Changes in Postmenopausal Women With Breast Cancer in Adjuvant Treatment With Anastrozole; ODM derived from: https://clinicaltrials.gov/show/NCT00623519

Link

https://clinicaltrials.gov/show/NCT00623519

Stichworte

  1. 11.07.16 11.07.16 -
Hochgeladen am

11. Juli 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer NCT00623519

Eligibility Breast Cancer NCT00623519

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
provision of informed consent
Beschreibung

informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
resectable breast cancer patients, with histological confirmation
Beschreibung

histological breast cancer

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0019638
UMLS CUI [1,2]
C0678222
UMLS CUI [1,3]
C1514888
patients eligible to receive hormonal adjuvant treatment with anastrozole
Beschreibung

hormone therapy with anastrozole

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0290883
UMLS CUI [1,2]
C0279025
they are allowed patients treated with adjuvant chemo or radiotherapy concurrently
Beschreibung

adjuvant chemo or radiotherapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0085533
UMLS CUI [2]
C1522449
patients previously treated with tamoxifen that had to withdraw treatment due to other reason than endometrial changes are allowed
Beschreibung

Tamoxifen treatment

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0039286
UMLS CUI [1,2]
C0949878
postmenopausal patients(aged 50 years or over/ without menses in the last months/ fsh level >40ui/l / women under 50 years with fsh levels>40ui/l).
Beschreibung

postmenopausal patients

Datentyp

boolean

Alias
UMLS CUI [1]
C0232970
women showing progesterone and/or estrogen receptors positive.
Beschreibung

progesterone and/or estrogen receptors positive.

Datentyp

boolean

Alias
UMLS CUI [1]
C1562029
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with evidence of metastatic disease
Beschreibung

metastatic disease

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1282506
UMLS CUI [1,2]
C0027627
patients unsuitable to receive the medication according the anastrozole label
Beschreibung

patients unsuitable to receive the medication according the anastrozole label

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0290883
UMLS CUI [1,2]
C3839996
patients not giving their informed consent
Beschreibung

informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430

Ähnliche Modelle

Eligibility Breast Cancer NCT00623519

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
informed consent
Item
provision of informed consent
boolean
C0021430 (UMLS CUI [1])
histological breast cancer
Item
resectable breast cancer patients, with histological confirmation
boolean
C0019638 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C1514888 (UMLS CUI [1,3])
hormone therapy with anastrozole
Item
patients eligible to receive hormonal adjuvant treatment with anastrozole
boolean
C0290883 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
adjuvant chemo or radiotherapy
Item
they are allowed patients treated with adjuvant chemo or radiotherapy concurrently
boolean
C0085533 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
Tamoxifen treatment
Item
patients previously treated with tamoxifen that had to withdraw treatment due to other reason than endometrial changes are allowed
boolean
C0039286 (UMLS CUI [1,1])
C0949878 (UMLS CUI [1,2])
postmenopausal patients
Item
postmenopausal patients(aged 50 years or over/ without menses in the last months/ fsh level >40ui/l / women under 50 years with fsh levels>40ui/l).
boolean
C0232970 (UMLS CUI [1])
progesterone and/or estrogen receptors positive.
Item
women showing progesterone and/or estrogen receptors positive.
boolean
C1562029 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
metastatic disease
Item
patients with evidence of metastatic disease
boolean
C1282506 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
patients unsuitable to receive the medication according the anastrozole label
Item
patients unsuitable to receive the medication according the anastrozole label
boolean
C0290883 (UMLS CUI [1,1])
C3839996 (UMLS CUI [1,2])
informed consent
Item
patients not giving their informed consent
boolean
C0021430 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video